Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1839]
News [4199]
Articles [376]
Editorials [10]
Conferences [103]
elearning [29]
High tumour immune cell levels may help screen HER2-positive breast cancer...
Dr Edith Perez - Mayo Clinic, Rochester, USA
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
12 Dec 2014
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of...
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Comment: Tamoxifen lowered breast cancer rates among high-risk women
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Tamoxifen lowered breast cancer rates among high-risk women ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
Impact of adding bevacizumab to presurgery chemo for triple-negative breast...
Dr William Sikov - Women and Infants Hospital, Providence, USA
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )
12 Dec 2014
Fulvestrant improves survival over anastrozole for patients with advanced...
Prof John Robertson - Royal Derby Hospital, Derby, UK
Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )
12 Dec 2014
Progression-free survival results from BOLERO-1 trial
Prof Sara Hurvitz - University of California, Los Angeles, USA
Progression-free survival results from BOLERO-1 trial ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Lowering dietary fat intake reduces death rates in some women with breast cancer
Prof Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA
Lowering dietary fat intake reduces death rates in some women with breast cancer ( Prof Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA )
12 Dec 2014
Multigene test can predict risk of disease recurrence for women with ductal...
Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
12 Dec 2014
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal...
Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )
11 Dec 2014
Comment: Capecitabine for elderly early-stage breast cancer
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Capecitabine for elderly early-stage breast cancer ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
11 Dec 2014
Capecitabine monotherapy does not improve survival in elderly patients with...
Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany
Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer ( Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany )
11 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation